Effect of Shexiang Tongxin dropping pill on stable coronary artery disease patients with normal fractional flow reserve and coronary microvascular disease: A study protocol.
Yanli LuXiaopeng ChuJiefang ZhangYanbo ZhaoChongying JinJunhui ZhuGuosheng FuFuyu QiuPublished in: Medicine (2020)
This is a protocol for the randomized clinical trial which has been registered in the Chinese clinical Trial Registry with an identifier: ChiCTR2000032429.
Keyphrases
- coronary artery disease
- clinical trial
- study protocol
- randomized controlled trial
- double blind
- percutaneous coronary intervention
- cardiovascular events
- open label
- coronary artery bypass grafting
- phase ii
- coronary artery
- placebo controlled
- phase iii
- aortic stenosis
- type diabetes
- heart failure
- acute coronary syndrome
- transcatheter aortic valve replacement
- atrial fibrillation